advertisement
Ahmad S 23
Showing records 1 to 23 | Display all abstracts from Ahmad S100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Lambuk L
Frontiers in pharmacology 2022; 13: 875662
100406 Head and Neck Region Dermatological Ultraviolet-Related Cancers are Associated with Exfoliation Syndrome in a Clinic-Based Population
Huang JJ
Ophthalmology. Glaucoma 2022; 5: 663-671
100787 Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma
Lambuk L; Ahmad S
Frontiers in immunology 2022; 13: 857812
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Mohd Lazaldin MA
Frontiers in pharmacology 2022; 13: 875662
100406 Head and Neck Region Dermatological Ultraviolet-Related Cancers are Associated with Exfoliation Syndrome in a Clinic-Based Population
Geduldig JE; Jacobs EB
Ophthalmology. Glaucoma 2022; 5: 663-671
100787 Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma
Sadikan MZ
Frontiers in immunology 2022; 13: 857812
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Ahmad S
Frontiers in pharmacology 2022; 13: 875662
100787 Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma
Nordin NA
Frontiers in immunology 2022; 13: 857812
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Iezhitsa I
Frontiers in pharmacology 2022; 13: 875662
100406 Head and Neck Region Dermatological Ultraviolet-Related Cancers are Associated with Exfoliation Syndrome in a Clinic-Based Population
Tai TYT
Ophthalmology. Glaucoma 2022; 5: 663-671
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Agarwal R
Frontiers in pharmacology 2022; 13: 875662
100787 Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma
Kadir R
Frontiers in immunology 2022; 13: 857812
100406 Head and Neck Region Dermatological Ultraviolet-Related Cancers are Associated with Exfoliation Syndrome in a Clinic-Based Population
Ahmad S; Chadha N
Ophthalmology. Glaucoma 2022; 5: 663-671
100787 Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma
Nasir NAA
Frontiers in immunology 2022; 13: 857812
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Uskoković V
Frontiers in pharmacology 2022; 13: 875662
100406 Head and Neck Region Dermatological Ultraviolet-Related Cancers are Associated with Exfoliation Syndrome in a Clinic-Based Population
Buxton DF
Ophthalmology. Glaucoma 2022; 5: 663-671
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Mohamud R; Mohamud R
Frontiers in pharmacology 2022; 13: 875662
100787 Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma
Chen X; Boer J
Frontiers in immunology 2022; 13: 857812
100406 Head and Neck Region Dermatological Ultraviolet-Related Cancers are Associated with Exfoliation Syndrome in a Clinic-Based Population
Vinod K; Wirostko BM
Ophthalmology. Glaucoma 2022; 5: 663-671
100787 Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma
Plebanski M
Frontiers in immunology 2022; 13: 857812
100406 Head and Neck Region Dermatological Ultraviolet-Related Cancers are Associated with Exfoliation Syndrome in a Clinic-Based Population
Kang JH
Ophthalmology. Glaucoma 2022; 5: 663-671
100787 Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma
Mohamud R; Mohamud R
Frontiers in immunology 2022; 13: 857812
100406 Head and Neck Region Dermatological Ultraviolet-Related Cancers are Associated with Exfoliation Syndrome in a Clinic-Based Population
Wiggs JL; Ritch R; Pasquale LR
Ophthalmology. Glaucoma 2022; 5: 663-671
